Norlase Wins PRISM Award for LYNX™ Pattern LIO

Norlase •  FEBRUARY 3, 2025  •  news

    

Norlase Wins PRISM Award for LYNX™ Pattern LIO

Norlase •  FEBRUARY  3, 2025  •  news

    

Ballerup, Denmark and Redwood City, CA, USA – February 3, 2025 – Norlase, a global leader in ophthalmic laser technology, has been honored with the prestigious PRISM Award in the Biomedical category for its latest innovation, LYNX™. This marks Norlase’s second PRISM Award win, following the success of LION®, further cementing the company’s reputation for pioneering advancements in retinal laser treatment.

LYNX is the world’s first pattern laser indirect ophthalmoscope (LIO), redefining efficiency, accessibility, and portability in retinal laser therapy. This groundbreaking device integrates advanced laser and pattern-scanning technology into a lightweight, wearable headset, eliminating the need for bulky external laser sources and complex setups.

Ophthalmologists face increasing patient volumes amid a nationwide physician shortage. LYNX is designed to help meet this challenge—its streamlined, ergonomic design enhances workflow efficiency, allowing retina specialists to perform laser treatments anywhere, with greater flexibility and ease.

“At Norlase, we are dedicated to developing technology that empowers ophthalmologists and enhances patient care,” said Oliver Hvidt, CEO and Co-Founder of Norlase. “Winning this award reinforces our commitment to delivering smart, efficient, and user-friendly solutions that optimize time and resources for busy practices.”

Often referred to as the “Oscars of Photonics,” the PRISM Awards celebrate the most impactful innovations in optics and photonics worldwide. Norlase’s recognition underscores its role in advancing ophthalmic laser treatment, making cutting-edge technology more accessible and efficient than ever before.

For more information about LYNX™, visit www.norlase.com.

About Norlase

Norlase develops next-generation laser solutions for the treatment of retina and glaucoma diseases. Founded in Denmark, Norlase is made up of worldwide industry experts in ophthalmology, laser technology, medical device development, and customer care. Norlase is on a mission to improve practice efficiency, patient care, and physician convenience for ophthalmologists worldwide. Norlase products include LEAF, a laser photocoagulator that’s 10x smaller than existing systems and mounts directly on the slit lamp; LION, the first fully integrated green laser and LIO; ECHO, the world’s first ultra-portable pattern scanning laser; and LYNX, the world’s first fully-integrated pattern LIO. Learn more at norlase.com.

Ballerup, Denmark and Redwood City, CA, USA – February 3, 2025 – Norlase, a global leader in ophthalmic laser technology, has been honored with the prestigious PRISM Award in the Biomedical category for its latest innovation, LYNX™. This marks Norlase’s second PRISM Award win, following the success of LION®, further cementing the company’s reputation for pioneering advancements in retinal laser treatment.

LYNX is the world’s first pattern laser indirect ophthalmoscope (LIO), redefining efficiency, accessibility, and portability in retinal laser therapy. This groundbreaking device integrates advanced laser and pattern-scanning technology into a lightweight, wearable headset, eliminating the need for bulky external laser sources and complex setups.

Ophthalmologists face increasing patient volumes amid a nationwide physician shortage. LYNX is designed to help meet this challenge—its streamlined, ergonomic design enhances workflow efficiency, allowing retina specialists to perform laser treatments anywhere, with greater flexibility and ease.

“At Norlase, we are dedicated to developing technology that empowers ophthalmologists and enhances patient care,” said Oliver Hvidt, CEO and Co-Founder of Norlase. “Winning this award reinforces our commitment to delivering smart, efficient, and user-friendly solutions that optimize time and resources for busy practices.”

Often referred to as the “Oscars of Photonics,” the PRISM Awards celebrate the most impactful innovations in optics and photonics worldwide. Norlase’s recognition underscores its role in advancing ophthalmic laser treatment, making cutting-edge technology more accessible and efficient than ever before.

For more information about LYNX™, visit www.norlase.com.

About Norlase

Norlase develops next-generation laser solutions for the treatment of retina and glaucoma diseases. Founded in Denmark, Norlase is made up of worldwide industry experts in ophthalmology, laser technology, medical device development, and customer care. Norlase is on a mission to improve practice efficiency, patient care, and physician convenience for ophthalmologists worldwide. Norlase products include LEAF, a laser photocoagulator that’s 10x smaller than existing systems and mounts directly on the slit lamp; LION, the first fully integrated green laser and LIO; ECHO, the world’s first ultra-portable pattern scanning laser; and LYNX, the world’s first fully-integrated pattern LIO. Learn more at norlase.com.

DIDN’T FIND WHAT YOU’RE LOOKING FOR?

Let us know how we can help!

DIDN’T FIND WHAT YOU
WERE LOOKING FOR?

Let us know how we can help!